China SXT Pharmaceuticals Inc (SXTC) News

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   AMENDMENT...

China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

TAIZHOU, China, May 10, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company...

Statement of Ownership (sc 13g)

 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 13G  Under the Securities Exchange...

Amended Statement of Ownership (sc 13g/a)

 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 13G  Under the Securities Exchange...

Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)

    Filed pursuant to Rule 424(b)(7)   Registration No. 333-252664   Prospectus Supplement (To...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form...

Amended Statement of Ownership (sc 13g/a)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF...

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Jiangsu, China, Nov. 07, 2022 (GLOBE NEWSWIRE) --  China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   RE...

Annual and Transition Report (foreign Private Issuer) (20-f)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 20-F  ...

China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

TAIZHOU, China, May 18, 2022 (GLOBE NEWSWIRE) --  China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT...